Handbook of Pharmaceutical Excipients, NEW 7th edition.
A new edition of the Handbook has always seen important developments, and this edition is no exception. Not only has the entire volume been reviewed and updated, significant new content has been added.
Special offer price - available now.
A new edition of the Handbook has always seen important developments, and this edition is no exception. Not only has the entire volume been reviewed and updated, significant new content has been added.
This includes 40 new monographs – bringing the total to 380 – written by a team of over 150 of the world’s leading pharmaceutical scientists. Monographs are extensively illustrated with images(SEMs), chemical structures, spectra and tables to support easy interpretation of the text.
With every new edition, the Handbook has increased in breadth and depth, making it increasingly valuable to drug formulators, manufacturers, regulatory and legal bodies, and establishing it as the go-to reference work on excipients. Pharmacists and chemists – in practice, in training and at work in a wide variety of industries – rely upon its authority and trust its content.
No reference work surpasses the Handbook of Pharmaceutical Excipients in the international recognition of the authority of its content and the respect for its editorial board and contributors.
“…the publisher and editors have once again published an excellent book which has utility for all of us involved in the pharmaceutical industry.” .
The British Toxicology Society
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
